Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomatitis 1Lung Neoplasms 1Head and Neck Neoplasms 1Fatigue 1Cachexia 1

Interventions

Megestrol Acetate 4Mirtazapine 2ostarine 1nabiximols 1clazakizumab 1anamorelin 1Sodium Chloride 1Physical Therapy Modalities 1Omacor 1Olanzapine 1Nutrition Assessment 1Megestrol 1Infliximab 1Ibuprofen 1Gemcitabine 1Flurandrenolone 1Fecal Microbiota Transplantation 1Cyproheptadine 1Clarithromycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Cachexia × clazakizumab × Clear all
NCT00866970 2020-07-09

Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia

CSL Behring

Phase 2 Completed
124 enrolled
Thoracic

Cachexia, Fatigue, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡